| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/02/2011 | US7989594 Modified antibody fab fragments |
| 08/02/2011 | US7989204 Hepatocyte lineage cells |
| 08/02/2011 | US7989193 Compositions and methods for producing gamma-carboxylated proteins |
| 08/02/2011 | US7989191 Mutant 6-phosphogluconate dehydrogenase |
| 08/02/2011 | US7989189 Mutant GTP cyclohydrolase II enzymes |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7989181 Methods and compositions for producing recombinant proteins using a gene for TRNA |
| 08/02/2011 | US7989171 Anti-human tenascin monoclonal antibody |
| 08/02/2011 | US7989161 Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system |
| 08/02/2011 | US7988979 Neisseria meningitidis antigens and compositions |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988964 NOGO-a neutralising immunoglobulin for treatment of neurological diseases |
| 08/02/2011 | CA2505067C Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2329683C Iga nephropathy-related dna |
| 08/02/2011 | CA2323757C Antibody variants and fragments thereof |
| 08/02/2011 | CA2321169C Modified enzymes and their use for peptide synthesis |
| 08/02/2011 | CA2320220C Isolated dna or gene responsible for parkinson's disease |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 08/02/2011 | CA1341619C Recombinant inhibin |
| 07/28/2011 | WO2011091370A1 Methods of intracellular conversion of single-chain proteins into their di-chain form |
| 07/28/2011 | WO2011091350A2 Methods & compositions for improving protein production |
| 07/28/2011 | WO2011090804A1 Targeted genomic alteration |
| 07/28/2011 | WO2011089170A2 Process for preparing fgf-21 with low degree of o-glycosylation |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184147 Enzyme substrate for labeling of protein |
| 07/28/2011 | US20110184049 Liver-specific nucleic acid regulatory elements and methods and use thereof |
| 07/28/2011 | US20110183917 P53 Activator Peptides |
| 07/28/2011 | US20110183916 Apo-2 Ligand |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183861 Methods to stabilize proteins and polypeptides |
| 07/28/2011 | US20110183402 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 07/28/2011 | US20110183377 Methods, systems and reagents for improved immunodetection |
| 07/28/2011 | US20110183376 Novel anti-igf-ir antibodies and uses thereof |
| 07/28/2011 | US20110183375 Metal binding compounds and their use in cell culture medium compositions |
| 07/28/2011 | US20110183374 Thiopeptide precursor protein, gene encoding it and uses thereof |
| 07/28/2011 | US20110183373 Recombinant peptide production using a cross-linkable solubility tag |
| 07/28/2011 | US20110183354 HUMAN Fc GAMMA RECEPTOR III |
| 07/28/2011 | US20110183037 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182923 Novel group b streptococcus antigens |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182919 Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| 07/28/2011 | US20110182905 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 07/28/2011 | US20110182904 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 07/28/2011 | US20110182900 Compositions and methods for treating coagulation related disorders |
| 07/28/2011 | US20110182899 Anti-glycoptrotein vi scfv fragment for treatment of thrombosis |
| 07/28/2011 | US20110182897 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 07/28/2011 | US20110182896 CLOTTING FACTOR-Fc CHIMERIC PROTEINS TO TREAT HEMOPHILIA |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182890 Anti-pleiotrophin antibodies and methods of use thereof |
| 07/28/2011 | US20110182879 Novel human transferase family members and uses thereof |
| 07/28/2011 | US20110182868 Human lysosomal proteins from plant cell culture |
| 07/28/2011 | US20110182811 Nucleotide sequence encoding a modulator of nf-kb |
| 07/28/2011 | CA2788074A1 Methods of intracellular conversion of single-chain proteins into their di-chain form |
| 07/28/2011 | CA2787942A1 Methods & compositions for improving protein production |
| 07/28/2011 | CA2785971A1 Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348126A2 Production of anti-amyloid beta antibodies |
| 07/27/2011 | EP2348053A2 Oligopeptide ligands |
| 07/27/2011 | EP2348051A2 CD20 antibodies with increased fc receptor binding affinity and effector function |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348047A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2347038A1 Methods of humanizing and affinity-maturing antibodies |
| 07/27/2011 | EP2347004A1 Reagents and methods for detecting a polymorphic protein |
| 07/27/2011 | EP2346987A1 Hydrophobin solution containing antifoam |
| 07/27/2011 | EP1885753B1 Production of recombinant Il-18 binding protein |
| 07/27/2011 | EP1832654B1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/27/2011 | EP1811027B1 Polynucleotide for production of recombinant protein by silkworm |
| 07/27/2011 | EP1732946B1 Dimeric fusion proteins and materials and methods for producing them |
| 07/27/2011 | EP1599578B1 Methods for preventing gluconoylation of proteins |
| 07/27/2011 | EP1594543B1 Immunogene adherence inhibitor and method of making and using the same |
| 07/27/2011 | CN1896267B Preparation of depressor peptide by silkworm chrysalis |
| 07/27/2011 | CN1854306B Production of recombinant human serum albumin HSA by fermentation |
| 07/27/2011 | CN102137935A Factor VIII muteins with reduced immunogenicity |
| 07/27/2011 | CN102137870A Antibody directed against PcrV |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134556A Culture medium composite used for culturing glutathione productive yeast |
| 07/27/2011 | CN102134278A Preparation of subunit vaccine for mucosal immune in circovirus genetic engineering and application thereof |
| 07/27/2011 | CN102134277A Soluble VEGFR (Vascular Endothelial Growth Factor Receptor) difunctional chimera receptor VEGFR31-Ig as well as preparation method and application thereof |
| 07/27/2011 | CN102134275A 表皮生长因子受体变异体 Epidermal growth factor receptor variant |
| 07/27/2011 | CN102134274A tGLP-1 derivative as well as preparation and application thereof |
| 07/27/2011 | CN102134270A Preparation and expression of pig propagation and respiration syndrome virus vaccine antigen N protein |
| 07/27/2011 | CN101696239B Human oocyte zona pellucida protein multi-epitope chimeric peptide antigen and preparation method thereof |
| 07/27/2011 | CN101560473B Strain with high destruxins yield and application thereof |
| 07/27/2011 | CN101560257B Heavy metal copper monoclonal antibody and preparation method thereof |
| 07/27/2011 | CN101538328B Humanized neutralizing engineered antibody for targeting avian influenza virus H5N1 |
| 07/27/2011 | CN101200751B Method for preparing hairtail polypeptides |
| 07/27/2011 | CN101084302B Recombinant microorganism |
| 07/27/2011 | CN101067124B Novel peptide synthase gene |
| 07/27/2011 | CN101062949B Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof |
| 07/27/2011 | CN101010427B Anti-A33 antibody |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |